Business context and reporting period
Filing identity differs from the request metadata: the supplied Form 20-F is for Fanhua Inc. (ticker FANH), not AIFU Inc. It is an annual report for the fiscal year ended December 31, 2022, not a standalone 2022 fourth-quarter report. The filing does not provide clear standalone Q4 financial results. Financial statements are prepared under U.S. GAAP and audited by Deloitte Touche Tohmatsu Certified Public Accountants LLP.
Fanhua is a Cayman Islands holding company operating mainly in China as an insurance intermediary and claims-adjusting provider. It distributes life, health and property-and-casualty insurance and provides claims-adjusting services. Investors should note that part of its online insurance business is conducted through consolidated variable interest entities (VIEs) controlled by contracts rather than direct ownership.
Financial results and key metrics
| Metric | FY 2022 | FY 2021 | Change |
|---|---|---|---|
| Net revenue | RMB2,781.6 million (US$403.3 million) | RMB3,271.1 million | Down 15.0% |
| Operating income | RMB168.7 million | RMB301.9 million | Down 44.1% |
| Net income | RMB85.7 million | RMB259.9 million | Down 67.0% |
| Net income attributable to Fanhua shareholders | RMB100.3 million | RMB251.0 million | Down 60.0% |
| Operating cash flow | RMB137.8 million | RMB126.2 million | Up |
- Revenue mix: life insurance generated RMB2,237.3 million, or 80.4% of revenue; P&C insurance generated RMB139.5 million, or 5.0%; claims adjusting generated RMB404.8 million, or 14.6%.
- Margins: operating margin was approximately 6.1%, versus 9.2% in 2021. Net income attributable to shareholders was approximately 3.6% of revenue, versus 7.7%.
- Cash flow: investing activities used RMB127.6 million and financing activities used RMB20.4 million. Cash, cash equivalents and restricted cash ended the year at RMB648.2 million, compared with RMB656.5 million a year earlier.
- Liquidity and debt: year-end cash and cash equivalents were RMB567.5 million and short-term investments were RMB347.8 million. Current assets were RMB2,293.6 million versus current liabilities of RMB952.0 million. Short-term borrowings were RMB35.7 million; operating lease liabilities totaled RMB136.5 million. Restricted cash was RMB80.7 million.
- Balance sheet: total assets were RMB3,089.5 million and total liabilities RMB1,358.2 million at year-end. The filing reports RMB1,399.7 million of undistributed PRC earnings available for distribution, subject to legal and regulatory restrictions.
Material changes versus the prior comparable period
- Revenue fell 15.0%, chiefly due to a 16.5% decline in life-insurance revenue and an 11.9% decline in claims-adjusting revenue. Management cited COVID-related disruption, a strong 2021 comparison base for critical-illness policies, and a lower weighted-average renewal commission rate.
- Life-insurance gross written premiums nevertheless rose 10.2% to RMB12,409.0 million: first-year premiums rose 2.0% to RMB2,556.9 million and renewal premiums rose 12.6% to RMB9,852.1 million.
- Operating expenses declined 12.0%, less than the revenue decline, and operating income fell 44.1%. Claims adjusting shifted from RMB16.8 million operating income to an RMB11.9 million operating loss.
- Share of income and impairment of affiliates was a net loss of RMB69.6 million, including a RMB78.3 million impairment of the CNFinance investment. Fanhua distributed most of its CNFinance shares to shareholders in June 2022 and reduced its stake from approximately 18.5% to approximately 0.01%.
- Cash used in investing activities replaced the prior-year inflow, reflecting investment purchases and prepayments, lending to third parties, and higher capital spending. Year-end short-term investments declined to RMB347.8 million from RMB870.7 million.
Outlook, management commentary, risks and unusual items
- Outlook: management says current cash and expected operating cash flow should cover anticipated needs for at least 12 months. No numerical earnings or revenue guidance is provided. Priorities include professionalizing and expanding the agent network, digital capabilities, an open platform, marketing and selective acquisitions.
- Revenue-estimate sensitivity: 2022 life-insurance revenue included RMB245.7 million of estimated renewal commissions. The estimate depends on future policy renewals and performance targets; management reduced the constraint applied to estimated renewal commissions from 86% to 69%. The auditor identified this estimation as a critical audit matter.
- Acquisitions after year-end: Fanhua entered agreements to acquire Zhongrong, Zhongji and Taiping. By March 31, 2023, it had acquired 53.44% of Zhongrong and completed the Zhongji and Taiping acquisitions. Share consideration and performance targets may affect final consideration; the filing says accounting for these acquisitions was still being assessed.
- Other unusual items: the company recognized RMB30.7 million of credit-loss provisions in 2022 and reported RMB36.6 million of uncertain tax liabilities at year-end. It launched a US$20 million ADS repurchase program in December 2022; by March 31, 2023, repurchases totaled approximately US$0.6 million.
- Principal risks: dependence on insurance-company relationships and productive agents; changing Chinese insurance and data-protection rules; COVID-related disruption; competition and commission-rate pressure; foreign-exchange and cash-transfer restrictions; and PRC legal and regulatory uncertainty surrounding VIE arrangements. The VIEs represented 5.1% of consolidated revenue and 3.3% of assets in 2022, but their contracts have not been tested in court.
- Market-access risk: the PCAOB said in December 2022 it had obtained inspection access to mainland China and Hong Kong audit firms, removing the immediate HFCA Act trading-prohibition risk described in the filing. Future access could change. The company also describes CSRC filing requirements for future offshore offerings and capital raises.
- Legal and controls: the company reported no material pending legal proceeding; regulatory fines in 2022 totaled RMB1.0 million and were described as immaterial. Management and the auditor concluded internal control over financial reporting was effective at December 31, 2022. The financial-statement audit opinion was unqualified.
Most important facts for investors to verify
- Confirm the issuer: the filing is for Fanhua Inc. (FANH), not AIFU Inc.; confirm whether this is the intended filing.
- Review the full audited statements and notes, especially the RMB245.7 million estimated renewal-commission revenue, related contract assets, and assumptions behind renewal rates.
- Assess the causes and sustainability of lower operating income and net income, including the claims-adjusting loss and corporate strategy spending.
- Check collectability and terms of the RMB180.0 million of third-party term loans due in June 2023, and the remaining liquidity available after restricted cash and planned spending.
- Track integration, performance targets, share issuance and final accounting for the Zhongrong, Zhongji and Taiping acquisitions.
- Assess the enforceability and regulatory standing of the VIE arrangements, and the ability to transfer cash from PRC entities to the holding company and shareholders.
- Monitor insurance-company concentration, particularly Sinatay’s 19.6% revenue contribution, and the impact of regulatory or commission changes.